Literature DB >> 9560126

Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma.

M Miyazaki1, H Ito, K Nakagawa, S Ambiru, H Shimizu, Y Shimizu, A Okuno, S Nozawa, Y Nukui, H Yoshitomi, N Nakajima.   

Abstract

Major hepatic resection for biliary tract carcinoma with obstructive jaundice has been reported on as bringing about high surgical morbidity and mortality rates. It has been also revealed that the extent of hepatic resection is closely associated with the occurrence of postoperative complications. Therefore, hepatic resection, limited as much as possible to what is necessary for curative resection, should be performed according to cancer extent. We performed a new surgical approach in 3 patients with hepatic hilar cholangiocarcinoma that included total resection of hepatic segments I and IV (by Couinaud's classification) and bile duct resection with hepaticojejunostomy of 4 to 6 intrahepatic bile duct stumps. All patients underwent curative surgical resections and were discharged within 6 weeks after surgery, without any serious complications. This limited resection of hepatic segments I and IV could be an effective radical surgical procedure for hepatic hilar cholangiocarcinoma, to avoid the occurrence of postoperative liver failure.

Entities:  

Mesh:

Year:  1998        PMID: 9560126     DOI: 10.1016/s0002-9610(97)00295-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Preoperative evaluation with T-staging system for hilar cholangiocarcinoma.

Authors:  Ru-Fu Chen; Zhi-Hua Li; Jia-Jia Zhou; Jie Wang; Ji-Sheng Chen; Qing Lin; Qi-Bing Tang; Ning-Fu Peng; Zhi-Peng Jiang; Quan-Bo Zhou
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

2.  S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.

Authors:  Y Kawarada; S Isaji; H Taoka; M Tabata; B C Das; H Yokoi
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

3.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

4.  Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma.

Authors:  Jin Hong Lim; Gi Hong Choi; Sung Hoon Choi; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

5.  Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer?

Authors:  Hiroshi Shimada; Itaru Endo; Mitsutaka Sugita; Hideki Masunari; Yoshiro Fujii; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2003-02-28       Impact factor: 3.445

Review 6.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 7.  Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice.

Authors:  Takashi Tajiri; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Shigeki Yokomuro; Yoshiaki Mizuguchi
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

8.  Radical surgery of left-sided klatskin tumors.

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.

Authors:  Jun-Jie Xiong; Quentin M Nunes; Wei Huang; Samir Pathak; Ai-Lin Wei; Chun-Lu Tan; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.